Michael F. DeBruin

Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy Subjects

Barry Dvorchik, D J Brazier, Michael F. DeBruin et al. · Antimicrobial Agents and Chemotherapy · 2003 · 357 citations · Full text

Drug Safety, Healthy Subjects, Antibiotics +15

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease

Bruce E. Sands, Simmy Bank, Charles A. Sninsky et al. · Gastroenterology · 1999 · 205 citations · Full text

Inflammation, Autoimmune Disease, Mucosal Immunology +10

Phase 1 Trial of a Single Dose of Recombinant Human Interleukin–12 in Human Immunodeficiency Virus–Infected Patients with 100–500 CD4 Cells/μL

Mark Z. Jacobson, David J. Hardy, Elizabeth Connick et al. · The Journal of Infectious Diseases · 2000 · 42 citations · Full text

A Multicenter Study of Recombinant Human Interleukin 12 for the Treatment of Chronic Hepatitis C Virus Infection in Patients Nonresponsive to Previous Therapy

Paul J. Pockros, Keyur Patel, Christopher O’Brien et al. · Hepatology · 2003 · 40 citations · Full text